Purchase Order 36C24226P0660

The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a $38,875.02 firm fixed-price purchase order to Theracom, L.L.C. on March 18, 2026 for the supply of TAKHZYRO 150MG/ML injection in 2ML syringe formulation. The contract, which will be completed by March 25, 2026, was awarded without a set-aside designation and will be performed at Theracom's location in Brooks, Kentucky. Theracom is a specialty pharmaceutical distributor headquartered in Shepherdsville,...

The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a firm fixed-price purchase order to Theracom, L.L.C. for TAKHZYRO 150MG/ML injection in 2ML syringe formulation on February 24, 2026. The contract has a ceiling value of $38,875.02 with an ultimate completion date of March 24, 2026. The award was made without a set-aside designation, reflecting full and open competition. Theracom, a Kentucky-based pharmaceutical specialty distributor headquartered in...

<p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on May 19, 2026, with completion by May 20, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. The order is firm fixed-price for the supply of this specialized pharmaceutical therapy to the federal healthcare system.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52. The contract was awarded on April 28, 2026, with an ultimate completion date of May 9, 2026. Theracom, a Kentucky-based pharmaceutical specialty distributor and child entity of Cencora, Inc. (doing business as AmerisourceBergen), will perform this work at its location in Brooks, Kentucky. This...

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. for $38,097.52 for the supply of TAKHZYRO 150 MG, a specialized biologic pharmaceutical therapy. The contract was awarded on March 2, 2026, with an ultimate completion date of March 4, 2026, and no set-aside designation was utilized. Theracom, headquartered in Shepherdsville, Kentucky and operating from its Brooks, Kentucky facility, is a specialized...

Theracom, L.L.C., a child entity, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 2 on October 20, 2025, for the supply of TAKHZYRO (pegtanercept) 150MG/ML injection in a 2ML syringe formulation. This is a pharmaceutical supply contract with a ceiling value of approximately $37.7K, with an ultimate completion date of November 20, 2025. The contract was awarded without a set-aside designation, and the place of performance is listed as Brooks, Kentucky. This...

This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awards Takeda Pharmaceuticals America Inc. a $36,890.40 firm fixed price contract to supply TAKHZYRO 150MG/ML SYRINGE 2ML PER SYRINGE with a quantity of 2. The contract is issued against Takeda Pharmaceuticals America Inc.'s existing Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking place in Lexington, Massachusetts. No...

Takeda Pharmaceuticals America Inc. was awarded a $36,984.28 firm fixed-price delivery order for TAKHZYRO 150 MG, a specialized pharmaceutical treatment for hereditary angioedema. The contract, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, is a child order under Takeda's broader Blanket Purchase Agreement with the VA National Acquisition Center valued at $131.04 million. The award was issued without a set-aside designation, reflecting the specialized and...

The Defense Logistics Agency awarded a $34,342.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Takhzyro 300 mg/2 ml syringes on April 25, 2025, with completion required by May 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation, and...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Takhzyro 300 mg/2 ml syringe, 2 ml, with a ceiling value of $18,640.57.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 4, 2026. No set-aside was used.</p>